전미영
#통합내과#입원의학#소화기질환#간질환 (Liver disease)
|
학력
ㆍ 경상대학교 의과대학 석사 (2012)
ㆍ 연세대학교 의과대학 박사 과정
ㆍ 연세대학교 의과대학 박사 과정
경력
ㆍ 2012-2013 신촌세브란스병원 인턴
ㆍ 2013-2017 신촌세브란스병원 내과 전공의
ㆍ 2017-2018 신촌세브란스병원 소화기내과 전임의
ㆍ 2018-2019 신촌세브란스병원 소화기내과 임상연구조교수
ㆍ 2019-현재 신촌세브란스병원 통합내과 진료교수
ㆍ 2013-2017 신촌세브란스병원 내과 전공의
ㆍ 2017-2018 신촌세브란스병원 소화기내과 전임의
ㆍ 2018-2019 신촌세브란스병원 소화기내과 임상연구조교수
ㆍ 2019-현재 신촌세브란스병원 통합내과 진료교수
논문
Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis
HEPATOLOGY INTERNATIONAL 11/3 :268-276,2017
Gamma-glutamyl transpeptidase-to-platelet ratio is an independent predictor of hepatitis B virus-related liver cancer
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 32/6 :1,221-1,229,2017
Additive endoscopic resection may be sufficient for patients with a positive lateral margin after endoscopic resection of early gastric cancer
GASTROINTESTINAL ENDOSCOPY 86/5 :849-856,2017
Survival Estimates after Stopping Sorafenib in Patients with Hepatocellular Carcinoma: NEXT Score Development and Validation
GUT AND LIVER 11/5 :693-701,2017
Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B
LIVER INTERNATIONAL 38/4 :676-686,2018
Reproducibility of European Association for the Study of the Liver criteria and modified Response Evaluation Criteria in Solid Tumors in patients treated with sorafenib
LIVER INTERNATIONAL 38/9 :1,655-1,663,2018
Long-term outcomes after noncurative endoscopic resection of early gastric cancer: the optimal time for additional endoscopic treatment
GASTROINTESTINAL ENDOSCOPY 87/4 :1003-1015,2018
Predictors of Discordance in the Assessment of Skeletal Muscle Mass between Computed Tomography and Bioimpedance Analysis
Journal of Clinical Medicine 7/8 :3-,2019
Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection
PLOS ONE 14/4 :e0214613-,2019
Conditional Survival Estimates Improve Over Time for Patients with Hepatocellular Carcinoma: An Analysis for Nationwide Korea Cancer Registry Database
CANCER RESEARCH AND TREATMENT 51/4 :1,347-1,356,2019
Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
Clinical and molecular hepatology 25/3 :283-293,2019
HEPATOLOGY INTERNATIONAL 11/3 :268-276,2017
Gamma-glutamyl transpeptidase-to-platelet ratio is an independent predictor of hepatitis B virus-related liver cancer
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 32/6 :1,221-1,229,2017
Additive endoscopic resection may be sufficient for patients with a positive lateral margin after endoscopic resection of early gastric cancer
GASTROINTESTINAL ENDOSCOPY 86/5 :849-856,2017
Survival Estimates after Stopping Sorafenib in Patients with Hepatocellular Carcinoma: NEXT Score Development and Validation
GUT AND LIVER 11/5 :693-701,2017
Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B
LIVER INTERNATIONAL 38/4 :676-686,2018
Reproducibility of European Association for the Study of the Liver criteria and modified Response Evaluation Criteria in Solid Tumors in patients treated with sorafenib
LIVER INTERNATIONAL 38/9 :1,655-1,663,2018
Long-term outcomes after noncurative endoscopic resection of early gastric cancer: the optimal time for additional endoscopic treatment
GASTROINTESTINAL ENDOSCOPY 87/4 :1003-1015,2018
Predictors of Discordance in the Assessment of Skeletal Muscle Mass between Computed Tomography and Bioimpedance Analysis
Journal of Clinical Medicine 7/8 :3-,2019
Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection
PLOS ONE 14/4 :e0214613-,2019
Conditional Survival Estimates Improve Over Time for Patients with Hepatocellular Carcinoma: An Analysis for Nationwide Korea Cancer Registry Database
CANCER RESEARCH AND TREATMENT 51/4 :1,347-1,356,2019
Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
Clinical and molecular hepatology 25/3 :283-293,2019
저서
저서 내용이 없습니다.
보도자료
보도자료 내용이 없습니다.
포스팅
포스팅 내용이 없습니다.
영상자료
영상자료 내용이 없습니다.
발표자료
발표자료 내용이 없습니다.